Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (FY)2025/09/30 | (Q1)2024/12/31 | (FY)2024/09/30 | (Q2)2024/03/31 | (Q1)2023/12/31 | (FY)2023/09/30 | (Q4)2023/09/30 | (Q3)2023/06/30 | (Q2)2023/03/31 | (Q1)2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 9.85%55.01億 | 9.80%13.09億 | 33.66%50.07億 | 33.53%12.54億 | 49.45%11.93億 | 49.69%37.46億 | 24.09%10.86億 | 65.10%9.24億 | 71.02%9.39億 | 53.67%7.98億 |
| 主營業務成本 | 1.51%19.64億 | 5.76%4.87億 | 67.96%19.35億 | 78.52%4.93億 | 139.35%4.61億 | 185.99%11.52億 | 98.73%3.92億 | 288.29%2.92億 | 314.72%2.76億 | 200.98%1.93億 |
| 毛利 | 15.11%35.36億 | 12.34%8.22億 | 18.42%30.72億 | 14.79%7.61億 | 20.86%7.32億 | 23.54%25.94億 | 2.37%6.94億 | 30.50%6.32億 | 37.40%6.63億 | 32.98%6.05億 |
| 營業費用 | 18.16%19.3億 | 7.73%4.57億 | 9.00%16.33億 | 18.25%4億 | 14.28%4.24億 | 31.75%14.98億 | 18.74%4.04億 | 30.90%3.86億 | 34.88%3.38億 | 47.19%3.71億 |
| 營業利潤 | 11.64%16.07億 | 18.71%3.65億 | 31.30%14.39億 | 11.20%3.61億 | 31.27%3.08億 | 13.85%10.96億 | -14.10%2.9億 | 29.87%2.47億 | 40.13%3.25億 | 15.35%2.34億 |
| 營業外利息收入與支出淨額 | 67.58%-184.2萬 | 17.74%-136.3萬 | -58.60%-568.1萬 | -130.02%-138.7萬 | -195.89%-165.7萬 | -368.24%-358.2萬 | 25.66%-109.5萬 | -638.21%-132.4萬 | -348.15%-60.3萬 | -355.71%-56萬 |
| 營業外利息收入 | 494.85%439萬 | 1.64%12.4萬 | -10.65%73.8萬 | -49.07%13.7萬 | -49.38%12.2萬 | -14.58%82.6萬 | -21.62%20.3萬 | -54.07%11.3萬 | 10.70%26.9萬 | 10.05%24.1萬 |
| 營業外利息支出 | -2.91%623.2萬 | -16.41%148.7萬 | 45.62%641.9萬 | 74.77%152.4萬 | 122.10%177.9萬 | 154.50%440.8萬 | -25.06%129.8萬 | --143.7萬 | --87.2萬 | --80.1萬 |
| 投資淨收益 | 40.96%-69.9萬 | 51.61%-21.1萬 | 5.66%-118.4萬 | -233.93%-15萬 | 56.87%-43.6萬 | -68.01%-125.5萬 | -125.00%-18.2萬 | 72.73%-17.4萬 | 142.59%11.2萬 | -76.13%-101.1萬 |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | 0 | -3,352.24%-2,540萬 | 0 | |||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | 95.66%-372.3萬 | -91.30%51.3萬 | -397.57%-8,581.2萬 | -52.53%1,114.8萬 | 104.83%589.7萬 | 80.46%2,883.8萬 | -93.75%95.8萬 | 1,626.14%151.9萬 | 10,924.41%2,348.2萬 | 741.81%287.9萬 |
| 減:重組及並購 | --0 | ---- | --752.2萬 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| 減:其他特殊費用 | 120.19%372.3萬 | 91.30%-51.3萬 | 36.06%-1,844萬 | 52.53%-1,114.8萬 | -104.83%-589.7萬 | -80.46%-2,883.8萬 | 93.75%-95.8萬 | -1,626.14%-151.9萬 | -10,924.41%-2,348.2萬 | -741.81%-287.9萬 |
| 減:勾銷 | --0 | ---- | --9,673萬 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| 其他營業外收入(費用) | 108.61%1,246萬 | 14.09%272.1萬 | -37.47%597.3萬 | -136.62%-79.8萬 | 18.24%238.5萬 | 98.67%955.2萬 | -36.20%309.6萬 | 17,484.62%226萬 | 7,882.14%217.9萬 | 50,525.00%201.7萬 |
| 稅前利潤 | 19.25%16.13億 | 16.90%3.67億 | 22.48%13.52億 | 5.72%3.7億 | 32.04%3.14億 | 12.35%11.04億 | -18.18%2.93億 | 17.89%2.24億 | 50.88%3.5億 | 17.00%2.38億 |
| 所得稅 | 15.92%5.01億 | 23.77%1.31億 | 26.77%4.32億 | 9.18%1.2億 | 46.76%1.06億 | 14.74%3.41億 | -10.04%8,343萬 | 10.10%7,563.4萬 | 51.69%1.1億 | 13.81%7,221萬 |
| 除稅後利潤 | 20.82%11.12億 | 13.40%2.36億 | 20.56%9.2億 | 4.13%2.5億 | 25.62%2.08億 | 11.32%7.63億 | -21.03%2.09億 | 22.33%1.48億 | 50.51%2.4億 | 18.45%1.66億 |
| 持續經營利潤 | 20.82%11.12億 | 13.40%2.36億 | 20.56%9.2億 | 4.13%2.5億 | 25.62%2.08億 | 11.32%7.63億 | -21.03%2.09億 | 22.32%1.48億 | 50.51%2.4億 | 18.44%1.66億 |
| 歸屬于少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | 20.82%11.12億 | 13.40%2.36億 | 20.56%9.2億 | 4.13%2.5億 | 25.62%2.08億 | 11.32%7.63億 | -21.03%2.09億 | 22.33%1.48億 | 50.51%2.4億 | 18.45%1.66億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 20.82%11.12億 | 13.40%2.36億 | 20.56%9.2億 | 4.13%2.5億 | 25.62%2.08億 | 11.32%7.63億 | -21.03%2.09億 | 22.33%1.48億 | 50.51%2.4億 | 18.45%1.66億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 20.85%23.42 | 13.47%4.97 | 20.52%19.38 | 4.15%5.27 | 25.50%4.38 | 11.28%16.08 | -20.93%4.42 | 21.96%3.11 | 50.60%5.06 | 18.31%3.49 |
| 稀釋每股收益 | 20.85%23.42 | 13.47%4.97 | 24.39%19.38 | 10.47%5.2695 | 31.93%4.38 | 13.39%15.58 | -17.48%4.39 | 28.10%3.1 | 49.06%4.77 | 18.57%3.32 |
| 每股派息 | 15.38%7.5 | 0 | 18.18%6.5 | 0 | 0 | 83.33%5.5 | 83.33%5.5 | 0 | 0 | 0 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |